Barclays’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-97,141
| Closed | -$4.96M | – | 4642 |
|
|
2024
Q4 | $4.96M | Sell |
97,141
-190,938
| -66% | -$9.75M | ﹤0.01% | 1618 |
|
|
2024
Q3 | $11.9M | Buy |
288,079
+25,365
| +10% | +$1.05M | ﹤0.01% | 951 |
|
|
2024
Q2 | $12.7M | Sell |
262,714
-162,215
| -38% | -$7.81M | ﹤0.01% | 832 |
|
|
2024
Q1 | $20.4M | Buy |
424,929
+306,994
| +260% | +$14.7M | 0.01% | 735 |
|
|
2023
Q4 | $7.66M | Sell |
117,935
-132,127
| -53% | -$8.58M | ﹤0.01% | 1212 |
|
|
2023
Q3 | $16.4M | Buy |
250,062
+9,318
| +4% | +$609K | 0.01% | 728 |
|
|
2023
Q2 | $14M | Buy |
240,744
+147,828
| +159% | +$8.59M | 0.01% | 789 |
|
|
2023
Q1 | $5.74M | Buy |
92,916
+71,940
| +343% | +$4.44M | ﹤0.01% | 1010 |
|
|
2022
Q4 | $1.33M | Sell |
20,976
-12,838
| -38% | -$816K | ﹤0.01% | 1915 |
|
|
2022
Q3 | $2.46M | Buy |
33,814
+20,230
| +149% | +$1.47M | ﹤0.01% | 1518 |
|
|
2022
Q2 | $924K | Buy |
13,584
+4,655
| +52% | +$317K | ﹤0.01% | 2146 |
|
|
2022
Q1 | $809K | Buy |
+8,929
| New | +$809K | ﹤0.01% | 2469 |
|